mpox, Diagnostic Test
WHO approves first mpox diagnostic test for emergency use
The World Health Organization authorized Abbott Laboratories' mpox diagnostic test for emergency use on Thursday, the first such approval in the agency's effort to bolster testing capabilities in countries facing outbreaks of the disease.
WHO Approves Mpox Diagnostic Test, Hoping to Stop Spread of Virus
The first diagnostic test for mpox has been approved by the World Health Organization in a bid to expand its availability and stop the spread of lethal outbreaks of the disease in Africa.
As Cases Surge, First Mpox Diagnostic Test is Approved by WHO
A viral disease now known as mpox has been spreading infecting people at increasingly higher rates. It causes fever, chills, body aches, and skin lesions; | Clinical And Molecular Dx
WHO approves first mpox test for quick diagnosis
The World Health Organization (WHO) has approved the first diagnostic test for mpox where the results can be immediately known, saying it could prove pivotal in helping to stop the rising global cases of the deadly virus. The new PCR test enables the detection of the mpox DNA taken from skin lesion swabs.
WHO approves emergency use of first mpox test
The World Health Organization said Thursday it approved the first mpox invitro diagnostic for emergency use. The Affinity m MPXV assay, made by Abbott Molecular, will expand global diagnostic capacity.
WHO approves first mpox diagnostic test
The agency declared the disease a global health emergency in August after a new deadly strain began spreading in Africa.
WHO approves first Mpox diagnostic test for emergency use, boosting global access
The World Health Organization (WHO) has approved the first Mpox diagnostic test for emergency use for early diagnosis to enable timely treatment, care, and virus control. WHO approved the first Mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure,
WHO approves Abbott’s mpox test for emergency use
This first mpox in vitro diagnostic (IVD) listed under WHO’s Emergency Use Listing (EUL) procedure is an important step in improving global access to mpox testing. WHO Access to
Derbyshire Times3h
Mpox: symptoms to look out for as vaccine programme begins in DRC after global emergency declared by WHO
Mpox is caught through close contact. If you get infected, it usually takes between five and 21 days for the first symptoms ...
Opinion
Eagle-Tribune5hOpinion
Their View: WHO’s slow mpox response calls for a rethink
Although well-intended, WHO’s over-cautious and convoluted regulatory process stalled vaccine delivery for months before an approval was granted last month. Hundreds of lives were lost in the meantime ...
STAT22d
WHO pandemic threat director: Here’s what needs to happen to combat mpox
Van Kerkhove is interim director of the Department of Epidemic and Pandemic Threat Management, Health Emergencies Programme, World Health Organization. There is a pervasive myth that the ...
Reuters26d
WHO clears Bavarian Nordic's vaccine for mpox, sets up access scheme
WHO sets up access scheme for mpox vaccines, tests, treatments European countries, US, Japan pledge 3.6 mln doses for mpox WHO faces criticism for slow mpox vaccine approval process Sept 13 ...
Seattle Times25d
WHO authorizes mpox vaccine, clearing way for use in Africa
Mpox vaccine from U.S. arrives in Congo (Sept. 10) First 100,000 doses of mpox vaccine arrive in Congo, a fraction of what’s needed No vaccines, tests or treatments: Congo lacks tools to ...